| Contract Number | Active Ingredient | Therapeutic Code | Therapeutic Description |
|---|---|---|---|
| 41 | PEGFILGRASTIM | 2016 | HEMATOPOIETIC |
| 42 | FILGRASTIM | 2016 | HEMATOPOIETIC |
| 41 | FILGRASTIM | 2016 | HEMATOPOIETIC |
| 42 | PEGFILGRASTIM | 2016 | HEMATOPOIETIC |
| 41 | EPOIETIN ALPHA | 2016 | HEMATOPOIETIC |
| 42 | EPOIETIN ALPHA | 2016 | HEMATOPOIETIC |
| 41 | EPOIETIN BETA | 2016 | HEMATOPOIETIC |
| 42 | EPOIETIN BETA | 2016 | HEMATOPOIETIC |
| 40 | EPOIETIN BETA | 2016 | HEMATOPOIETIC |
| 40 | PENTOXIFYLLINE | 2024 | HEMORRHEOLOGICS |
| 42 | PENTOXIFYLLINE | 2024 | HEMORRHEOLOGICS |
| 41 | PENTOXIFYLLINE | 2024 | HEMORRHEOLOGICS |
| 42 | TRANEXAMIC ACID | 2028 | ANTIHEMORRHAGIC AGENTS |
| 41 | TRANEXAMIC ACID | 2028 | ANTIHEMORRHAGIC AGENTS |
| 40 | TRANEXAMIC ACID | 2028 | ANTIHEMORRHAGIC AGENTS |
| 42 | PROTAMINE SULPHATE | 202808 | ANTIHEPARIN |
| 41 | PROTAMINE SULPHATE | 202808 | ANTIHEPARIN |
| 40 | PROTAMINE SULPHATE | 202808 | ANTIHEPARIN |
| 40 | FACTOR IX | 202816 | HEMOSTATICS |
| 42 | FACTOR VIII | 202816 | HEMOSTATICS |